Cagrilintide for Sale — Research-Grade, COA-Tested
Looking to buy Cagrilintide? MyGLP1Store offers Cagrilintide for sale as a third-party lab-tested research peptide with a published Certificate of Analysis (COA), documented >99% purity, and same-day U.S. shipping. Veteran-owned and trusted by researchers (Trustpilot 4.8). For laboratory research use only.
Cagrilintide (CAGRI) – 5mg Lyophilized Research Peptide
Cagrilintide (research code AM833), listed in research catalogs as CAGRI, is a long-acting amylin analog studied in metabolic research models for its role in appetite regulation, satiety signaling, and energy balance. Amylin is a peptide hormone co-secreted with insulin; long-acting analogs such as cagrilintide are widely investigated in obesity and metabolic research, frequently alongside GLP-1 receptor agonists.
What Is Cagrilintide Used for in Research?
In laboratory settings, Cagrilintide (CAGRI) is explored for amylin-receptor signaling, food-intake regulation, post-meal glucose response, and combination models. One of the most studied combinations pairs Cagrilintide with Semaglutide — together referred to as CagriSema — to investigate complementary appetite and metabolic pathways. For a deeper overview, see our Cagrilintide research guide.
Product Details
- Peptide: Cagrilintide (CAGRI / AM833)
- Purity: >98% (HPLC verified)
- Form: Lyophilized powder
- Quantity: 5mg per vial
- Storage: Store at -20°C. After reconstitution, refrigerate at 2–8°C and use within 30 days.
Research Applications
- Amylin receptor pathway studies
- Appetite and satiety signaling research
- Glucose regulation and post-meal response models
- Energy balance and metabolic function investigations
- Combination research with GLP-1 receptor agonists (e.g., CagriSema)
Why Buy Cagrilintide From MyGLP1Store
Our CAGRI is third-party lab tested with a published Certificate of Analysis (COA) and documented purity. MyGLP1Store is a veteran-owned, U.S.-based supplier offering same-day domestic shipping and a verified Trustpilot rating of 4.8 — a trusted source for researchers looking to buy Cagrilintide research peptide in the United States.
Research References
- Lau DCW, et al. Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled, dose-finding phase 2 trial. Lancet. 2021;398(10317):2160–2170. PubMed
- Enebo LB, et al. Concomitant cagrilintide and semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial. Lancet. 2021;397(10286):1736–1748. PubMed
For laboratory and research use only. Not for human or veterinary consumption. Nothing here is medical advice or a dosing recommendation.








Reviews
There are no reviews yet.